Skip to main content
An official website of the United States government

sipuleucel-T

View Patient Information
A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP.
Synonym:APC8015 vaccine
PA2024 (PAP/GM-CSF)-loaded dendritic cell vaccine
SipT
US brand name:Provenge
Code name:APC 8015
APC8015
Search NCI's Drug Dictionary